Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Iqvia Holdings Inc.

Capitalization 29.97B 25.85B 23.35B 22.38B 40.67B 2,761B 42.52B 276B 111B 1,321B 113B 110B 4,740B P/E ratio 2026 *
21.6x
P/E ratio 2027 * 18.2x
Enterprise value 43.05B 37.13B 33.53B 32.14B 58.41B 3,966B 61.07B 396B 159B 1,897B 162B 158B 6,808B EV / Sales 2026 *
2.5x
EV / Sales 2027 * 2.31x
Free-Float
67.55%
Yield 2026 *
-
Yield 2027 * -
1 day-2.96%
1 week-0.49%
Current month-3.18%
1 month-5.12%
3 months-22.34%
6 months-5.85%
Current year-23.20%
1 week 171.7
Extreme 171.695
182.93
1 month 156.66
Extreme 156.665
185
Current year 156.66
Extreme 156.665
247.04
1 year 134.64
Extreme 134.645
247.04
3 years 134.64
Extreme 134.645
261.73
5 years 134.64
Extreme 134.645
285.61
10 years 61.21
Extreme 61.21
285.61
Manager TitleAgeSince
Chief Executive Officer 65 03/10/2016
Director of Finance/CFO 50 28/02/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 68 05/02/2015
Director/Board Member 60 01/01/2008
Chairman 65 03/10/2016
Change 5d. change 1-year change 3-years change Capi.($)
-2.99%-0.49%-8.30%-12.24% 29.97B
-0.31%-4.13%-8.71%-6.97% 44.96B
+1.50%+3.29%+26.44%+41.89% 33.54B
+0.98%-13.63%+16.43%+43.10% 30.24B
+0.74%-0.16%+172.49%+383.29% 19.78B
+0.63%+0.74%+74.40%+126.89% 14.73B
-1.39%+1.10%+39.45%+168.20% 13.58B
+0.38%-3.48%+22.17%+0.63% 12.97B
+1.39%-2.80%+137.31%+125.15% 12.45B
-0.85%+7.25%+23,702.04%+3,589.42% 12.81B
Average +0.03%-1.64%+2,417.37%+445.94% 22.5B
Weighted average by Cap. -0.02%-1.65%+1,383.62%+272.41%

Financials

2026 *2027 *
Net sales 17.24B 14.87B 13.43B 12.87B 23.39B 1,588B 24.46B 159B 63.58B 760B 64.72B 63.33B 2,727B 18.25B 15.74B 14.22B 13.62B 24.76B 1,681B 25.89B 168B 67.31B 804B 68.51B 67.04B 2,886B
Net income 1.45B 1.25B 1.13B 1.08B 1.97B 133B 2.06B 13.33B 5.34B 63.86B 5.44B 5.32B 229B 1.68B 1.45B 1.31B 1.25B 2.28B 155B 2.38B 15.46B 6.2B 74.07B 6.31B 6.17B 266B
Net Debt 13.08B 11.28B 10.19B 9.76B 17.74B 1,205B 18.55B 120B 48.23B 576B 49.09B 48.03B 2,068B 12.23B 10.55B 9.52B 9.13B 16.59B 1,126B 17.34B 112B 45.09B 539B 45.9B 44.91B 1,934B
Logo Iqvia Holdings Inc.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (40.6%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (4.9%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (47.5%), Europe and Africa (31.8%) and Asia/Pacific (20.7%).
Employees
93,000
Date Price Change Volume
10/03/26 173.08 $ -3.06% 542,456
09/03/26 178.55 $ +2.33% 1,979,321
06/03/26 174.49 $ -2.25% 1,766,022
05/03/26 178.50 $ +0.35% 2,101,693
04/03/26 177.88 $ +2.25% 1,778,975
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
178.55USD
Average target price
236.19USD
Spread / Average Target
+32.28%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW